← All indications
Hematopoietic Stem Cell Transplantation
Transfer of HEMATOPOIETIC STEM CELLS from BONE MARROW or BLOOD between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS). Hematopoietic stem cell transplantation has been used as an alternative to BONE MARROW TRANSPLANTATION in the treatment of a variety of neoplasms.
Subtype terms (1)
More specific conditions that are subtypes of Hematopoietic Stem Cell Transplantation in the MeSH hierarchy.
- Peripheral Blood Stem Cell Transplantation
20 drugs (17 approved, 3 experimental)
Drugs by status
Approved for this indication (2)
Phase 4 trials (28)
- decitabine
- vitamin d3
- iron
- plerixafor
- sorafenib
- epoetin
- micafungin
- tacrolimus
- l-glutamine
- haloperidol
- Filgrastim
- lornoxicam
- ledipasvir
- posaconazole
- drotrecogin alfa, activated
- thrombopoietin
- ruxolitinib
- cyclosporine
- mycophenolate
- sofosbuvir
- cyclophosphamide
- Anti-thymocyte Globulin (Rabbit)
- human papillomavirus 9-valent vaccine, recombinant
- methotrexate
- autologous mesenchymal stem cells
- fludarabine
- etoposide
- dexamethasone
Phase 3 trials (48)
- levofloxacin
- cladribine
- fluticasone
- avatrombopag
- anti-lymphocyte globulin
- acetylcysteine
- venetoclax
- busulfan
- efprezimod alfa
- salmeterol
- eltrombopag
- enalapril
- imatinib
- bone marrow derived mesenchymal stem cells
- haploidentical mononuclear cells
- hydroxyurea
- idarubicin
- DTaP, inactivated poliovirus, haemophilus influenzae b conjugate, hepatitis b vaccine
- ganciclovir
- ixazomib
- leucovorin
- olanzapine
- pneumococcal 13-valent conjugate vaccine
- ponatinib
- platelets
- sitagliptin
- semustine
- dasatinib
- allogeneic lymphocytes
- valganciclovir
- +18 more
Phase 2 trials (96)
- montelukast
- azacitidine
- methylprednisolone
- denosumab
- allogeneic natural killer cells
- maraviroc
- urea
- bendamustine
- lenalidomide
- loratadine
- clofarabine
- diphenhydramine
- deferasirox
- prednisone
- elotuzumab
- gemcitabine
- aciclovir
- naltrexone
- aldesleukin
- famotidine
- human lactoferrin peptide
- nivolumab
- inotuzumab ozogamicin
- itacitinib
- pembrolizumab
- krn-7000
- caspofungin
- l-leucyl-l-leucine methyl ester
- neihulizumab
- allogeneic stem cells
- +66 more
Phase 1 trials (32)
- cmv-specific t-cells
- selinexor
- goat milk
- somatropin
- soybean oil
- palifermin
- human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant
- olaptesed pegol
- pravastatin
- ipilimumab
- nicotinamide
- vorinostat
- zoledronic acid
- allogeneic adipose derived mesenchymal stem cell
- allogeneic cytomegalovirus-specific cytotoxic t lymphocytes
- autologous cd34+ cells
- autologous regulatory t cells
- cd45-depleted allogenic peripheral blood stem cell
- human placental derived stem cells
- multivirus specific t cells
- interferon gamma-1b
- emapalumab-lzsg
- fish oil
- t lymphocytes
- ifn-gamma-secreting hadv antigen specific t cells
- rgi-2001
- allogeneic transplant donor lymphocytes, depleted of tcr-αβ t cells and b cells; enriched for nk cells and tcrγδ t cells
- Embryonic Stem Cells
- norovirus -specific t-cell
- ser-155
- +2 more
Other trials (24)
- thalidomide
- entecavir
- ethanol
- leuprolide
- hetrombopag olamine
- insulin human
- piperacillin
- valsartan
- hepatitis b vaccine (recombinant)
- teicoplanin
- epstein-barr virus cytotoxic t lymphocytes
- live attenuated varicella vaccine
- albuterol
- cord blood stem cells
- meropenem
- basiliximab
- sacubitril
- orange oil
- sodium chloride
- vitamin a
- tazobactam
- quercetin
- interferon alpha-2b
- COVID-19 convalescent plasma